Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News
  • Stocks
  • Premium
Back

Stocks to Watch: Bharat Dynamics Lands ₹2095 Cr Defence Deal, CESC Plans Mega ₹4500 Cr Plant, Zydus Pharma Navigates USFDA!

Economy

|

Updated on 14th November 2025, 1:49 AM

Whalesbook Logo

Author

Aditi Singh | Whalesbook News Team

alert-banner
Get it on Google PlayDownload on App Store

Crux:

Indian stock markets are set for active trading with key developments. Bharat Dynamics secured a major ₹2,095 crore defence contract. CESC's subsidiary will invest ₹4,500 crore in a solar and battery manufacturing facility in Odisha. Zydus Lifesciences received USFDA approval for a multiple sclerosis drug, though facing two inspection observations. Additionally, numerous companies like Tata Motors, Hero MotoCorp, and Marico are releasing their quarterly earnings, adding to the day's market focus.

Stocks to Watch: Bharat Dynamics Lands ₹2095 Cr Defence Deal, CESC Plans Mega ₹4500 Cr Plant, Zydus Pharma Navigates USFDA!

▶

Stocks Mentioned:

Bharat Dynamics Limited
Sagility Limited

Detailed Coverage:

Several Indian companies are in the spotlight today due to significant corporate announcements and financial results.

**Bharat Dynamics Limited** has signed a substantial contract worth ₹2,095.70 crore with the Ministry of Defence for the supply of Invar anti-tank missiles to the Indian Army. This order is expected to boost the company's revenue and order book.

**CESC Green Power**, a subsidiary of CESC Limited, has received in-principle approval from the Government of Odisha to establish a major manufacturing facility. This facility will include 3 GW solar cell and module capacity, a 5 GWh advanced chemistry battery cell pack unit, and a 60 MW AC captive power plant, with an estimated investment of around ₹4,500 crore spread across three phases. This marks a significant move into renewable energy and battery storage.

**Zydus Lifesciences Limited** underwent a Pre-Approval Inspection by the United States Food and Drug Administration (USFDA) at its Ahmedabad site. The inspection concluded with two observations, but importantly, no data-integrity issues were noted. Furthermore, Zydus received final USFDA approval for its Diroximel Fumarate delayed-release capsules, 231 mg, used for treating relapsing forms of multiple sclerosis.

**Nippon Life India Asset Management Limited** is entering a strategic collaboration with DWS Group GmbH & Co. KGaA, a European asset manager. DWS plans to acquire a minority stake of up to 40% in Nippon Life India AIF Management, aiming to build a leading Alternative Investment Fund (AIF) franchise in India.

**Sagility Limited** is expected to see activity as a promoter entity plans to sell up to a 16.4% stake via block deals.

Additionally, a long list of companies including Tata Motors, Hero MotoCorp, Marico, Glenmark Pharmaceuticals, and many others are set to release their quarterly earnings reports, providing investors with crucial financial data.

Impact This news is highly relevant to the Indian stock market. Several key companies have significant corporate actions including major order wins, large investment plans, and crucial regulatory updates. The release of quarterly earnings for many listed entities will also influence investor sentiment and specific stock movements. The direct impact on the Indian business environment and market performance is substantial. Rating: 8/10


Tech Sector

🚀 SaaS Giant Capillary Technologies IPO Launches: Price Band Revealed, Valuations Spark Debate!

🚀 SaaS Giant Capillary Technologies IPO Launches: Price Band Revealed, Valuations Spark Debate!

Infosys Rs 18,000 Cr Buyback: Record Date TODAY! Are Your Shares Eligible?

Infosys Rs 18,000 Cr Buyback: Record Date TODAY! Are Your Shares Eligible?

Pine Labs IPO Listing Today: Is a 2.5% Profit Gain on Cards? Find Out Now!

Pine Labs IPO Listing Today: Is a 2.5% Profit Gain on Cards? Find Out Now!

Pine Labs IPO: Big Wins & Painful Losses – Who Hit Jackpot, Who Faced Ruin?

Pine Labs IPO: Big Wins & Painful Losses – Who Hit Jackpot, Who Faced Ruin?

OpenAI CEO Sam Altman Drops MAJOR Bombshell: India Is Set to Be Their BIGGEST Partner!

OpenAI CEO Sam Altman Drops MAJOR Bombshell: India Is Set to Be Their BIGGEST Partner!

Physics Wallah IPO Allotment Day! Listing Buzz Builds - Don't Miss These Key Updates!

Physics Wallah IPO Allotment Day! Listing Buzz Builds - Don't Miss These Key Updates!


Startups/VC Sector

India's Startup IPO Frenzy: Investors Minting Fortunes as Market Booms!

India's Startup IPO Frenzy: Investors Minting Fortunes as Market Booms!